ProShares UltraShort Health Care (RXD) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the ProShares UltraShort Health Care stock forecast from 0 analysts, the average analyst target price for ProShares UltraShort Health Care is not available over the next 12 months. ProShares UltraShort Health Care’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ProShares UltraShort Health Care is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, ProShares UltraShort Health Care’s stock price was USD 11.62. ProShares UltraShort Health Care’s stock price has changed by +0.16% over the past week, +9.76% over the past month and -4.83% over the last year.
No recent analyst target price found for ProShares UltraShort Health Care
No recent average analyst rating found for ProShares UltraShort Health Care
Company Overview ProShares UltraShort Health Care
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. The fund is non-diversified. Read Less
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health...Read More
Frequently Asked Questions About ProShares UltraShort Health Care (RXD) Stock
Stock Target Advisor's fundamental analysis for ProShares UltraShort Health Care's stock is Very Bearish.
RXD stock's dividend yield is 4.42%.
Our analysis grades RXD stock's dividend yield at F. This means that RXD stock's dividend yield is above 26% of the stocks in the Trading--Inverse Equity sector in the NYE exchange.
Based on this RXD may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on RXD's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on RXD's stock to indicate if its overvalued.
The last closing price of RXD's stock was USD 11.62.
The most recent market capitalization for RXD is USD 1.09M.
Unfortunately we do not have enough analyst data on RXD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ProShares UltraShort Health Care's stock.
Sorry, we do not have any data on the number of employees for ProShares UltraShort Health Care.
Sorry we do not have any infomation available on ProShares UltraShort Health Care's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RXD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
